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Background: This twin study investigated whether autistic traits during childhood were associated with adolescent
psychotic experiences.
Methods: Data were collected from a community sample of approximately 5000 twin pairs, which included 32
individuals with diagnosed autism spectrum conditions (ASC). Parents rated autistic traits in the twins at four points
between ages 8–16 years. Positive, negative, and cognitive psychotic experiences were assessed at age 16 years
using self- and parent-report scales. Longitudinal twin analyses tested the associations between these measures.
Results: Autistic traits correlated weakly or nonsignificantly with positive psychotic experiences (paranoia,
hallucinations, and grandiosity), and modestly with cognitive psychotic experiences (cognitive disorganisation).
Higher correlations were observed for parent-rated negative symptoms and self-reported anhedonia, although the
proportion of variance in both accounted for by autistic traits was low (10 and 31 %, respectively). The majority of
the genetic influences on negative symptoms and anhedonia were independent of autistic traits. Additionally,
individuals with ASC displayed significantly more negative symptoms, anhedonia, and cognitive disorganisation
than controls.
Conclusions: Autistic traits do not appear to be strongly associated with psychotic experiences in adolescence;
associations were also largely restricted to negative symptoms. Of note, the degree to which the genetic and
environmental causes of autistic traits influenced psychotic experiences was limited. These findings thus support a
phenotypic and etiological distinction between autistic traits and psychotic experiences.
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Autism spectrum conditions (ASC) are characterised by
atypical social communication and behavioural inflexibil-
ity [1]. While historically viewed as childhood schizo-
phrenia, evidence on psychotic disorders in individuals with
ASC is mixed. While some studies report a very low preva-
lence of psychotic disorders amongst individuals with ASC
[2–4], others have reported prevalence as high as 13 % [5].
Psychotic experiences are milder manifestations of
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creativecommons.org/publicdomain/zero/1.0/[6–9]. While evidence on clinical psychotic disorders in in-
dividuals with ASC is inconsistent, psychotic experiences
appear relatively commonly in individuals with ASC [10,
11]. In two studies, negative symptoms were elevated in
young children with ASC [12, 13]. In another, 5.4 % of chil-
dren with ASC reported hallucinations [14]. Thus, the find-
ings to date suggest that particular psychotic experiences
may present relatively frequently in children with ASC.
Psychotic experiences are associated with elevated dis-
tress, suicide risk, and subsequent psychotic disorders
[15–17], and so, there is a need to understand why they
co-occur with ASC. There is some indication of overlap-
ping causes between clinical psychotic disorders and ASC.
ASC and schizophrenia seem to run together in the same
families [18], and there is tentative evidence that certainticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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picture is not clear, however; certain copy-number vari-
ants are unique to each condition, while a low genetic cor-
relation, calculated using common SNPs, has been
reported (.16) [19, 20].
It is also unknown whether the association between
ASC and psychotic experiences is due to shared causes.
Psychotic experiences display modest to moderate herit-
ability across differing severity levels [21]. Likewise, sub-
clinical autistic traits are highly heritable, again
consistently across different severity levels [22]. If there
is genetic overlap between clinical forms of these traits,
one might hypothesise that the causes of autistic traits
and psychotic experiences will also overlap. That is, one
might predict that the genetic variants underlying autis-
tic traits will also influence continuous variation in
psychotic experiences in the general population.
The twin design can address this question, as it allows
estimation of the extent of overlap in genetic and envir-
onmental influences between two traits. Prior studies of
ASC and psychotic experiences have employed data
from singletons [10–14], meaning that they were unable
to test the degree of genetic and environmental overlap
across these phenotypes. We therefore aimed to investi-
gate the degree to which the causes of autistic traits
across an 8-year period of childhood would account for
adolescent psychotic experiences. Psychotic experiences
comprise multiple factors [8, 23]; hence, we focused on
individual psychotic experiences in adolescence. We
also examined whether individuals with ASC displayed
more psychotic experiences than typically developing
individuals.
We expected genetic influences on autistic traits to ac-
count for a significant degree of variance in adolescent
psychotic experiences, specifically negative symptoms
[13, 14]. Individuals with ASC were expected to display
more negative symptoms, in particular, than typically de-
veloping individuals.
Methods
Participants
Participants were taking part in the Twins Early Devel-
opment Study (TEDS), a community sample of twins
born in England and Wales between 1994 and 1996 [24].
When twins were aged 16, 10,874 families were invitedTable 1 Interpretation of twin correlations
Component Cross-twin correlation
Additive genetic (A) MZ correlation is higher than the DZ corr
Shared environmental (C) DZ correlation is greater than half the MZ
Nonshared environmental (E) MZ correlation is lower than 1
Cross-twin correlation: correlation of one twin’s score on a trait with their co-twin’s
twin’s score on a trait with their co-twin’s score on another
MZ monozygotic twins, DZ dizygotic twinsto take part in the Longitudinal Experiences And Per-
ceptions (LEAP) study, a study of psychotic experiences
in the general population. In total, 5128 parents returned
LEAP data, while 5074 twin pairs both returned ques-
tionnaires. Participating and nonparticipating families in
LEAP were similar on various demographic characteris-
tics (shown in Additional file 1). Autistic traits were
assessed four times: at ages 8, 12, 14, and 16. All partici-
pants in LEAP who had autistic trait data at any prior
age were included in the study. Exclusions were
conducted for genetic syndromes, chromosomal abnor-
malities, perinatal/postnatal complications, and missing
first contact or zygosity data. The final sample sizes are
shown in Table 1. Zygosity was determined through par-
ent report of twin resemblance and DNA testing [25].
TEDS has full ethical approval from the King’s College
London, Institute of Psychiatry Ethics Committee. All
participants provided informed consent before complet-
ing questionnaires.
Measures
Autistic traits
Autistic traits were assessed at all four ages. At ages 8
and 12 years, parents completed the Childhood Autism
Spectrum Test (CAST [26]), a 31-item questionnaire (30
items were used at age 12 years due to the removal of an
age-inappropriate item). Each question was answered
‘yes’ or ‘no’; possible ranges of scores are shown in
Table 1. The measure was reliable (see Table 1) and
stable between ages 8 and 12 years (r = .55, p < .001).
Scores over 15 have 100 % sensitivity and 97 % specifi-
city in detecting individuals at risk of ASC, with a posi-
tive predictive value of 50 % [27]. The CAST was
divided into three previously published subscales [28]:
social difficulties, communication atypicalities, and re-
petitive behaviours and interests.
The CAST is a measure for elementary school-aged
children [26]; hence, parents completed the shortened
Autism Spectrum Quotient (AQ [29, 30]) at ages 14 and
16 years. The AQ comprised 38 items at age 14 years
and 28 items at age 16 years. Parents rated their agree-
ment with each item on a 4-point scale. The AQ was re-
liable (see Table 1) and stable between ages 14 and
16 years (r = .67, p < .001). Individuals with ASC scored
significantly higher on the AQ at ages 14 (t2546 = −9.43,Cross-trait cross-twin correlation
elation MZ correlation is higher than the DZ correlation
correlation DZ correlation is greater than half the MZ correlation
MZ correlation is lower than the phenotypic correlation
score on the same trait; cross-trait cross-twin correlation: correlation of one
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was divided into subscales [29]: social difficulties, com-
munication, imagination, attention to detail, and atten-
tion switching. Communication items were omitted
from the scale at age 16 owing to space constraints.
ASC diagnoses
Parents of twins scoring over 15 on the CAST were in-
vited to complete the Diagnostic and Well-Being Assess-
ment (DAWBA [31]), a structured interview for
establishing psychiatric diagnoses. Thirty-eight ASC-
relevant items were administered over the telephone.
The DAWBA effectively distinguishes between ASC
cases and controls30, and has good inter-rater reliability
(κ = 0.83) and internal consistency (α = 0.92) in this sam-
ple [32]. If either twin in a pair met DAWBA ASC cri-
teria, families were invited to take part in the Social
Relationships Study [33]. Two trained researchers visited
the families to complete the Autism Diagnostic Observa-
tion Schedule [34] with the twins and Autism Diagnostic
Interview-Revised [35] with the parents; these semi-
structured assessments are considered the ‘gold standard’
in diagnosing ASC in research. In total, 32 participants
with a confirmed diagnosis had Specific Psychotic Expe-
riences Questionnaire (SPEQ) data available (29 males, 3
females).
Psychotic experiences
Psychotic experiences at age 16 were assessed using the
SPEQ [8]. The SPEQ was constructed from six existing
measures of psychotic experiences in adults. The word-
ing of these measures was adapted for use with adoles-
cents, and the age appropriateness of the items was
established in terms of expert clinical opinion. Positive
and cognitive psychotic experiences were assessed using
four self-report measures: paranoia (15 items), hallucina-
tions (9 items), cognitive disorganisation (11 items), and
grandiosity (8 items). Negative symptoms were assessed
via a self-report measure of anhedonia (10 items) and a
parent measure of negative symptoms (9 items). The use
of both a parent- and self-report measure of negative
symptoms was designed to reflect recent recommenda-
tions that assessment of negative symptoms should in-
clude multiple informants [36]. One item (‘Has few or no
friends’) was removed from negative symptoms owing to
overlap with the autistic trait measures. Table 1 shows
ranges of scores and internal consistencies. All subscales
were stable across a 9-month period (r = .65–.74).
Principal-components analysis supported the division of
SPEQ into six subscales [8]. The measure has been vali-
dated against a similar measure, the Psychosis-Like Symp-
toms (PLIKS) scale [8, 37]. Individuals reporting having
‘definitely’ had psychotic experiences on the PLIKS scored
significantly higher on all SPEQ subscales than those whodid not (all p < .001). Individuals with relatives with
schizophrenia or bipolar disorder (N = 420, 227 males, 193
females) scored significantly higher on all SPEQ subscales
(p < .05), except for anhedonia and hallucinations (which
showed a nonsignificant trend).
Data analyses
Skewed measures were log transformed (Table 1). Sex
and age effects can inflate twin correlations (described
below). As a result, all scores were regressed for sex and
age, as is standard behavioural genetic procedure [38].
Two sets of analyses were performed. Multivariate twin
models were fitted to data on continuous autistic traits
and psychotic experiences in the whole sample. Mean
group differences in continuous SPEQ scores were then
compared in individuals with a diagnosis of ASC and
those without such a diagnosis.
Analyses were performed in the OpenMx [39] package
of R [40]. OpenMx uses full information maximum like-
lihood when fitting models, meaning that missing data
can be accounted for. Rather than excluding participants
with any missing data, full information maximum likeli-
hood includes participants with data for at least one age,
meaning that the sample is not limited by the presence
of missing data [39].
Phenotypic analyses
Phenotypic correlations (rph) between measures were es-
timated from twin models.
Mean standardised SPEQ scores were compared across
individuals with ASC and controls using independent
t tests. In addition, we tested whether individuals with a
family history of a psychotic disorder would display
more autistic traits than those without such a family his-
tory, again using independent t tests. Welch’s degrees of
freedom for unequal sample sizes were applied.
Twin analyses
The twin design seeks to partition variance in a pheno-
type into three components: additive genetic influences
(A); shared environmental influences (C), which are
common to both twins in a pair and cause similarity be-
tween them; and nonshared environmental influences
(E), which are unique to each twin and create differences
between them. These parameters are estimated on the
basis of the phenotypic resemblance of monozygotic
(MZ) twins, who share all their segregating DNA code,
and dizygotic (DZ) twins, who share on average 50 % of
their segregating DNA code.
Cross-twin correlations were used to establish the
phenotypic similarity of MZ and DZ twins. These corre-
lations, estimated from a saturated model of the
observed data, were obtained separately for MZ and DZ
twins, and involved correlating one twin’s score on a
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same trait. One can then gain an indication of the extent
of A, C, and E influences by examining the MZ and DZ
cross-twin correlations. Table 1 shows how the pattern
of cross-twin correlations can be interpreted.
The multivariate twin design allows one to investigate
the covariance between multiple traits by dividing the
correlation between them into A, C, and E components.
Cross-trait cross-twin correlations were estimated as a
starting point and involved correlating one twin’s autistic
traits with their co-twin’s psychotic experiences score.
Again derived separately for MZ and DZ twins, these
correlations can be used to obtain an initial indication of
the extent to which A, C, and E influence the covariance
between two traits. Table 1 shows how cross-trait cross-
twin correlations can be interpreted.
Structural equation twin-model fitting formally esti-
mated A, C, and E. Cholesky decompositions were fitted
to measures displaying sufficient covariance with one an-
other (rph > .20 at age 16). These decompositions esti-
mated the degree to which the causes of autistic traits
could account for psychotic experiences. In Fig. 1, the
pathways from latent variables (enclosed in circles) A1,
C1, E1, A2, C2, E2, A3, C3, E3, A4, C4, and E4 to SPEQ
subscales at 16 years denote the extent to which the
causes of autistic traits influence psychotic experiences.
In squaring these estimates, one can derive the propor-
tions of variance explained. A5, C5, and E5 represent re-
sidual variance in SPEQ scores that is unique to
psychotic experiences.
In the first instance, all estimates were free to differ by
sex (quantitative sex limitation), and were then equated
across sexes to test the significance of any sex differ-
ences. Parameters were then successively dropped fromFig. 1 Path diagram of the Cholesky decomposition. Variables enclosed in
E1–E4 to SPEQ age 16 represent the sources of shared variance between au
A5, C5, and E5 to SPEQ age 16, represent the residual variance in SPEQ subs
traits at each age. CAST Childhood Autism Spectrum Test, AQ Autism Spect
additive genetic influences, C shared environmental influences, E nonsharethe ACE Cholesky decomposition by fixing them to 0.
The fit of the Cholesky decompositions was compared
against a baseline-saturated model of observed means
and variances. The fit of each model was summarised by
the fit statistic which was −2 times the log likelihood of
the data (−2LL); differences in −2LL between two
models are χ2 distributed, with degrees of freedom
equivalent to the difference in number of parameters.
Significant χ2 results suggest a model is a significantly
poorer fit than the saturated model. Model fit was fur-
ther assessed using Akaike’s Information Criteria (AIC)
and Bayesian Information Criteria (BIC). Best-fitting
models were selected based on the most negative BIC
value.
Effects of two potential confounders were then tested:
general cognitive ability and internalising traits. A com-
posite g-score was computed when twins were aged 7,
12, 14, and 16 years [41]. At age 7, twins completed
three measures from the Wechsler Intelligence Test for
Children (WISC [42]): picture completion, vocabulary,
and similarities. Twins also completed the McCarthy
Conceptual Groups test [43]. At age 12, twins completed
the WISC vocabulary, picture completion, and general
knowledge tests [42] as well as the Raven’s Standard Pro-
gressive Matrices [44]. At ages 14 and 16, the Raven’s
Standard Progressive Matrices and WISC vocabulary
tests were administered. At each age, scores on all com-
pleted measures were standardised; g-score was calcu-
lated as the average of the standardised test scores at
each age.
Internalising traits were a second potential con-
founder. They were assessed using two self-report mea-
sures, the Childhood Anxiety Sensitivity Index [45] and
Short Moods and Feelings Questionnaire [46]. Analysescircles are latent variables. The red arrows connecting A1–A4, C1–C4, and
tistic traits and SPEQ subscale scores. The blue arrows, which connect
cales scores. The black arrows represent the paths between autistic
rum Quotient, SPEQ Specific Psychotic Experiences Questionnaire, A
d environmental influences
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out of all measures.
Results
Phenotypic analyses
Descriptive statistics are in Table 2 and are shown by
sex and zygosity in Additional file 2. Table 2 shows rph
estimates; at age 16 years, the highest estimates were be-
tween autistic traits and negative symptoms (rph = .47,
p < .01), and autistic traits and anhedonia (rph = .30,
p < .01). rph showed a trend for increasing with age; rph
between autistic traits and negative symptoms increased
from .27 at age 8 years to .47 at age 16 years, and from
.14 to .30 for anhedonia. All other estimates were mod-
est (.00–.21); therefore, only negative symptoms and an-
hedonia were included in twin-model fitting.
Cross-sectionally, negative symptoms showed stronger
associations with attention switching (rph = .45, p < .01)Table 2 Sample size, descriptive statistics, and phenotypic correlatio
Sample sizes
Age N families contacted MZM
8 years 13,941 858
12 years 8438 814
14 years 11,118 529
16 years 10,874 738
Measure descriptive statistics
Measure Cronbach’s α Possible rang
CAST age 8 0.71 0–31
CAST age 12 0.73 0–30
AQ age 14 0.80 0–87
AQ age 16 0.80 0–80
SPEQ paranoia 0.93 0–72
SPEQ hallucinations 0.88 0–45
SPEQ cognitive disorganisation 0.77 0–11
SPEQ grandiosity 0.86 0–24
SPEQ anhedonia 0.78 0–50
SPEQ negative symptoms 0.86 0–27
Phenotypic correlations
Autistic traits age 8 Autistic traits
Paranoia .02 (ns) .06*
Hallucinations .07** .10**
Cognitive disorganisation .08** .12**
Grandiosity .04* .08**
Anhedonia .14** .18**
Negative symptoms .27** .32**
All means are given for untransformed scores; skew values are shown for the untra
parentheses. All Ns are number of twin pairs with data available at each age
SPEQ Specific Psychotic Experiences Questionnaire, CAST Childhood Autism Spectru
*p < .05; **p < .01and social difficulties (rph = .44, p < .01) than the other
AQ subscales, as did anhedonia (rph = .25–.37). A full
table of rph between psychotic experiences and the autis-
tic trait subscales is shown in Additional file 3.
Twin analyses
Twin correlations
Twin correlations are shown in Table 3. For autistic
traits, MZ cross-twin correlations were higher than DZ
estimates, suggesting A. MZ estimates were less than 1,
suggesting E, while DZ estimates all exceeded half the
MZ estimates, implicating C. For anhedonia and nega-
tive symptoms, MZ cross-twin correlations were higher
than DZ statistics, implicating A. MZ estimates were all
below 1, suggesting E. In all instances, the MZ cross-
trait cross-twin correlations between negative symptoms
and autistic traits, and anhedonia and autistic traits were
higher than the DZ estimates. This suggests that geneticns
DZM MZF DZF DZOS
804 1046 874 1659
775 1050 895 1601
463 662 548 911
686 1043 905 1560
e of scores x (SD) Skew
4.85 (3.09) 0.99 (−0.64)
4.62 (3.15) 1.24 (−0.48)
36.78 (12.16) 0.24 (0.21)
24.04 (10.62) 0.39 (0.36)
12.17 (10.62) 1.56 (−0.61)
4.66 (6.01) 2.08 (0.22)
3.96 (2.85) 0.44 (−0.63)
5.32 (4.43) 1.19 (−0.41)
16.36 (7.93) 1.14 (0.17)
2.63 (3.63) 2.32 (0.45)
age 12 Autistic traits age 14 Autistic traits age 16
.07** .10**
.13** .14**
.17** .21**
.04 (ns) .00 (ns)
.24** .30**
.40** .47**
nsformed measures, and then the standardised residuals used in analyses in
m Test, AQ Autism Spectrum Quotient, ns nonsignificant
Table 3 Twin correlations
Cross-twin correlations
MZM DZM MZF DZF DZOS
Estimate 95 % CI Estimate 95 % CI Estimate 95 % CI Estimate 95 % CI Estimate 95 % CI
Autistic traits age 8 .83 .81/.85 .37 .35/.39 .79 .76/.82 .45 .40/.49 .48 .44/.49
Autistic traits age 12 .79 .77/.82 .32 .29/.35 .76 .73/.79 .51 .47/.55 .41 .38/.45
Autistic traits age 14 .91 .88/.93 .54 .51/.56 .88 .85/.89 .62 .60/.66 .51 .47/.55
Autistic traits age 16 .92 .90/.95 .51 .48/.55 .82 .80/.87 .58 .55/.61 .46 .44/.50
Anhedonia .37 .31/.39 .19 .18/.22 .45 .42/.46 .17 .13/.19 .14 .12/.15
Negative symptoms .80 .78/.82 .59 .55/.60 .81 .78/.82 .52 .47/.54 .47 .44/.48
Cross-trait cross-twin correlations
MZM DZM MZF DZF DZOS
Estimate 95 % CI Estimate 95 % CI Estimate 95 % CI Estimate 95 % CI Estimate 95 % CI
Autistic traits age 8—anhedonia .18 .15/.22 .07 .03/.10 .22 .19/.23 .03 .01/.05 .08 .05/.09
Autistic traits age 12—anhedonia .20 .17/.23 .00 −.05/.04 .23 .19/.26 .07 .03/.09 .11 .05/.13
Autistic traits age 14—anhedonia .24 .15/.27 .16 .09/.20 .32 .21/.34 .12 .08/.15 .14 .04/.17
Autistic traits age 16—anhedonia .28 .24/.29 .15 .09/.17 .31 .29/.33 .11 .06/.12 .11 .09/.13
Autistic traits age 8—negative symptoms .22 .19/.23 .18 .15/.19 .24 .21/.25 .19 .15/.22 .20 .18/.22
Autistic traits age 12—negative symptoms .34 .31/.35 .24 .22/.25 .29 .27/.31 .19 .17/.22 .19 .15/.22
Autistic traits age 14—negative symptoms .37 .31/.44 .30 .22/.36 .32 .23/.36 .25 .18/.29 .24 .21/.27
Autistic traits age 16—negative symptoms .43 .42/.45 .31 .29/.34 .36 .34/.38 .30 .28/.36 .21 .19/.23
MZM monozygotic male, DZM dizygotic male, MZF monozygotic female, DZF dizygotic female, DZOS dizygotic opposite sex
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traits and negative symptoms, and autistic traits and
anhedonia.Twin-model fitting
Five-variable Cholesky decompositions were fitted to (1)
autistic traits and anhedonia, and (2) autistic traits and
negative symptoms. Model-fit statistics and parameter
estimates are shown in Table 4.Autistic traits and anhedonia An ACE decomposition
with no sex differences best fit autistic traits and anhe-
donia. Paths A1–A4, C1–C4, and E1–E4 in Fig. 1 denote
the genetic and environmental influences on childhood
autistic traits that also influence anhedonia at age
16 years. Summing these paths gives the total proportion
of variance in anhedonia explained by autistic traits. In
total, 10 % of the variance in anhedonia was explained
by autistic traits. Of this variance, half (5 %) was
explained by A influences on autistic traits, 3 % was due
to C influences shared with autistic traits, and 2 % was
due to E. Of the 90 % of variance in anhedonia that was
independent of autistic traits, 32 % was explained by A
and 58 % by E. Anhedonia was 37 % heritable, yet only
5/37 = 13.5 % of this heritability was due to genetic influ-
ences shared with childhood autistic traits.Autistic traits and negative symptoms An ACE Cho-
lesky composition with no sex differences best fit autistic
traits and negative symptoms. A, C, and E influences on
autistic traits between ages 8–16 years (A1–A4, C1–C4,
and E1–E4) accounted for 31 % of the variance in nega-
tive symptoms. Of this shared variance, 12 % was ex-
plained by A influences on autistic traits, 16 % was due
to C, and 3 % was due to E. Of the 69 % variance in
negative symptoms that was independent of autistic
traits, most (45 %) was explained by A, while C and E
comprised 10 % and 14 %, respectively. Negative symp-
toms were 57 % heritable, yet only 12/57 = 21 % of this
heritability was due to genetic influences shared with
childhood autistic traits.Controlling for confounders Controlling for g-score or
internalising traits resulted in nonsignificant reductions
in the phenotypic correlations. Consequently, we did not
repeat twin-model fitting on these adjusted scores (con-
tact the first author for details).Individuals with ASC
Mean standardised SPEQ scores for participants with
ASC are shown in Fig. 2. Mean scores for controls were
0 owing to the standardisation of scores. Individuals with
ASC displayed significantly higher scores than controls
for cognitive disorganisation (t24.54 = −6.68, p < .001,
Table 4 Twin-model fit statistics and parameter estimates
Comparative fit with saturated model Comparative fit with full ACE Cholesky
Model −2LL df Par. BIC Δχ2 Δdf p AIC Δχ2 Δdf p AIC
Autistic traits and anhedonia
(five-variable decompositions)
Saturated 63,287.21 27,375 260 −158948.70 – – – – – – – –
ACE sex diff. 63,489.32 27,535 100 −160045.50 202.11 160 <.05 −117.89 – – – –
ACE const. a 63,619.71 27,580 55 −160280.40 332.50 205 <.001 −77.50 130.39 45 <.001 40.39
AE const. 63,784.42 27,595 40 −160237.50 497.20 220 <.001 57.20 164.71 15 <.001 134.71
CE const. 64,974.16 27,595 40 −159047.80 1686.94 220 <.001 1246.94 1345.45 15 <.001 1324.45
E const. 71,621.98 27,610 25 −152521.80 8334.77 235 <.001 7864.77 8002.27 30 <.001 7942.27
Autistic traits and parent-rated negative
symptoms (five-variable decompositions)
Saturated 60,014.32 27,393 260 −162367.70 – – – – – – – –
ACE sex diff. 60,189.54 27,553 100 −163491.40 175.22 160 .19 −144.78 – – – –
ACE const. a 60,319.68 27,598 55 −163726.60 305.35 205 <.001 −104.65 130.13 45 <.001 40.13
AE 60,542.65 27,613 40 −163625.40 528.33 220 <.001 −7.02 222.98 15 <.001 192.98
CE 61,994.75 27,613 40 −162173.31 1980.42 220 <.001 1540.42 1675.07 15 <.001 1645.07
E 70,414.98 27,628 25 −153874.80 10400.66 235 <.001 9930.66 10095.31 30 <.001 10035.31
Parameter estimates from best-fitting
decompositions
Autistic traits age 8 Autistic traits age 12 Autistic traits age 14 Autistic traits age 16 Variance specific to
psychotic experiences
A1 C1 E1 A2 C2 E2 A3 C3 E3 A4 C4 E4 A5 C5 E5
Anhedonia .02 (.00/.05) .01 (.00/.05) .00 (−.01/.01) .00 (.00/.03) .01 (.00/.04) .00 (−.01/.01) .02 (.00/.05) .01 (.00/.04) .00 (.00/.01) .01
(.00/.05)
.00
(−.01/.03)
.02
(.00/.03)
.32
(.26/.36)
.00
(−.05/.06)
.58
(.55/.61)
Total .03 .01 .03 .03 .90
Neg sym .02 (.00/.04) .10 (.04/.22) .00 (.00/.01) .01 (.00/.03) .06 (.01/.17) .00 (.00/.01) .05 (.03/.10) .00
(−.01/.01)
.01 (.00/.01) .04
(.01/.07)
.00
(−.02/.02)
.02
(.01/.03)
.45 (.40/.50) .10
(−.18/.18)
.14
(.13/.15)
Total .12 .07 .06 .06 .69
AE, CE, and E models are submodels within the ACE model that fit best. A1–A4, C1–C4, and E1–E4 are the paths shown in red in Fig. 1, and represent the influence of genetic and environmental causes of autistic traits
on psychotic experiences, A5, C5, and E5 are residual pathways (shown in blue in Fig. 1), which represent the genetic and environmental influences on psychotic experiences that are independent of autistic traits
Saturated saturated model of means and covariance, ACE sex diff. full ACE Cholesky decomposition, which included quantitative sex differences for all parameters, ACE const. constrained ACE Cholesky decomposition,
with parameters fixed to be equal across sexes, −2LL fit statistic, df degrees of freedom, Par. parameters, AIC Akaike’s Information Criteria, BIC Bayesian Information Criteria, A additive genetic influences, C shared
environmental influences, E nonshared environmental influences
aIndicates best-fitting model
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Fig. 2 Mean standardised scores on the SPEQ subscales for participants with ASC. Error bars represent 95 % confidence intervals; all means are
given as mean standardised residual scores. SPEQ Specific Psychotic Experiences Questionnaire
Taylor et al. Molecular Autism  (2015) 6:44 Page 8 of 11r = .80), anhedonia (t24.20 = −2.55, p < .05, r = .46), and
negative symptoms (t24.20 = −2.55, p < .05, r = .80).
Family history of psychotic disorders
Mean AQ scores at age 16 were virtually identical across
individuals with a first-degree relative with a psychotic
disorder (x = 24.76 [SD = 11.68]) and those without (x =
24.14 [SD = 10.81]). Mean scores did not differ signifi-
cantly across individuals with and without a family his-
tory of a psychotic disorder, t489.53 = −1.04, p = .30.
Discussion
Childhood autistic traits, and diagnosed ASC, were associ-
ated with negative psychotic experiences in adolescence,
but not positive or cognitive psychotic experiences. As ex-
pected, twin modelling revealed a degree of shared genetic
and environmental influences between these traits, yet thiswas modest. The majority of variance in adolescent nega-
tive symptoms was independent of autistic traits. In
addition, there was no indication of an elevation in autistic
traits for individuals with a family history of psychotic dis-
orders. Thus, our results imply a limited association be-
tween autistic traits and psychotic experiences. These
findings could not be accounted for by general cognitive
ability or internalising traits.
Our findings concur with two previous studies in show-
ing that autistic traits are linked with negative symptoms,
in particular [13, 14], yet associations with positive and
cognitive psychotic experiences were weaker. These find-
ings seemingly contradict two community-based studies
[10, 11]. One possibility is that the use of different raters
for autistic traits and these psychotic experiences in our
study dampened the associations between them. This,
however, is unable to explain why the association with
Taylor et al. Molecular Autism  (2015) 6:44 Page 9 of 11negative symptoms held across both parent and self re-
ports. It is notable that, while the association was weaker
than with negative symptoms, cognitive psychotic experi-
ences still showed a stronger correlation with autistic
traits than positive symptoms in our study. It may, there-
fore, be that the previous findings were being driven by
cognitive symptoms.
One of the core questions posed in this study was
whether or not autistic traits would share genetic causes
with psychotic experiences. Could the genetic variants
associated with both ASC and schizophrenia, such as
calcium-signalling genes [19] and 16p11.2 duplications
[47, 48], mean that genetic factors might also play a role
in influencing the co-occurrence of autistic traits and
psychotic experiences in the general population? The
genetic influences on autistic traits accounted for some
variance in negative symptoms; however, this was only a
small proportion of variance. More importantly, autistic
traits were not as strongly linked with positive symp-
toms, such as paranoia, emphasising the possibility that
any genetic associations between autistic traits and
psychotic experiences are constrained to negative psych-
otic experiences. As such, we do not predict that studies
of the genetic basis of psychotic experiences are likely to
prove informative when attempting to understand the
aetiology of ASC.
In light of recent findings [19, 47, 48], some have argued
that clinical ASC and schizophrenia are part of a con-
tinuum of neurodevelopmental causality [49]. Indeed, there
is evidence of some genetic and environmental overlap
across autistic traits and traits of other conditions, includ-
ing ADHD and anxiety [50, 51]. The present findings can
be taken as partial support to the idea of a continuum of
neurodevelopmental conditions, with two key caveats. First,
the relationship between autistic traits and psychotic expe-
riences was limited to negative psychotic experiences.
Second, the majority of the genetic and environmental
influences on psychotic experiences were distinct from aut-
istic traits, tallying with SNP-based evidence reporting low
genetic correlations between ASC and schizophrenia [19].
As such, these findings converge to suggest that while there
is some overlap between these phenotypes, they are largely
separate, with low genetic overlap.
Given the modest role played by shared environment
in autistic traits [22] and psychotic experiences [21], it
is surprising that such influences on autistic traits
accounted for some variance in psychotic experiences.
The net influence of shared environment on anhedonia
was weak, however. The use of the same rater for nega-
tive symptoms and autistic traits may also have inflated
the role of shared environment in their covariance.
This study was not free from limitations. As with all
studies of co-occurrence of different traits that rely on
questionnaire data, there is some risk that items can beinterpreted in different ways by different people and as
such overlap could be for heterogeneous reasons. How-
ever, all the evidence here suggests that each of our mea-
sures is capturing what they aim to capture, and thus,
any overlap is due to true co-occurrence of psychotic ex-
periences and autistic traits in individuals.
A consideration is whether or not the association be-
tween autistic traits, anhedonia and negative symptoms,
was driven by phenotypic similarity of the items. In the
first instance, we removed an ostensibly overlapping
item from the negative symptoms subscale of the SPEQ
(‘Has few or no friends’). Additionally, the correlations
between scores on these measures were not total, indi-
cating a degree of independence between the measures.
Finally, our measures of autistic traits and psychotic ex-
periences both have good construct and content validity,
as outlined in the Methods‘’ section.
Some may query the use of self-report measures in in-
dividuals with ASC, but it needs to be noted that the ele-
vation in negative symptoms in individuals with ASC
was evident not only for self-reported anhedonia, but
also for parent-rated negative symptoms. It is worth not-
ing, however, that autistic traits were rated by parents
only. Future research should endeavour to obtain ratings
of autistic traits from multiple informants, for example
teachers in addition to parents. Finally, the use of a large
sample, a requisite for twin-model fitting, necessitated
the use of questionnaire measures over in-depth assess-
ments. As such, the sample comprised not only individ-
uals displaying very high scores on the measures, but
also a considerable number of individuals displaying
lower scores, resulting in skewed measures. This, how-
ever, is to be expected in large, community-based studies
of psychopathology.
While we had longitudinal data on autistic traits, we
did not have longitudinal data on psychotic experiences.
Longitudinal cross-lagged twin models can test whether
one phenotype directly leads to another e.g. [51], but the
absence of data on psychotic experiences at multiple
ages in our sample meant that this was not possible in
our study. Nevertheless, this would represent an import-
ant future direction for research.
One might question whether these twin findings gen-
eralise to singletons. Neither autistic traits [52] nor
psychotic experiences [8] appear elevated in twins rela-
tive to singletons. Studies of singletons have also re-
ported that psychotic experiences are elevated in
individuals with ASC [10–14].
Conclusions
These findings demonstrate that autistic traits and ASC
were linked with negative symptoms in adolescence,
such as anhedonia and affective flattening, but less so
with cognitive or positive psychotic experiences. In
Taylor et al. Molecular Autism  (2015) 6:44 Page 10 of 11clinics, therefore, one might expect to see individuals
with ASC present with more negative symptoms, rather
than positive symptoms, such as hallucinations and
paranoia. Despite the co-occurrence of autistic traits and
ASC with negative symptoms, however, genetic overlap
between them was low. There remains a considerable
amount of work to be done to fully unravel the genetic
basis of autistic traits and psychotic experiences. As we
learn more about the causes of these phenotypes, on the
basis of the present findings, we do not predict that the
same genetic variants will be identified as associated
with autistic traits and psychotic experiences.
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